Amneal Pharmaceuticals Inc Class A (AMRX)
Interest Expense
$227.46M
TTM · Period ending: · USD
AMRX Interest Expense
Latest reported$227.46Mperiod ending
Latest reported$227.46Mperiod ending
AMRX TTM Interest Expense ($56.90M → $227.46M)
TTM interest expense
High-resolution chart · PNG
AMRX interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 227,455,000 | |
| 237,513,000 | |
| 241,091,000 | |
| 246,516,000 | |
| 249,213,000 | |
| 249,831,000 | |
| 258,595,000 | |
| 256,481,000 | |
| 241,879,000 | |
| 227,017,000 | |
| 210,629,000 | |
| 198,109,000 | |
| 189,591,000 | |
| 174,357,000 | |
| 158,377,000 | |
| 145,306,000 | |
| 137,315,000 | |
| 135,775,000 | |
| 136,325,000 | |
| 136,903,000 | |
| 137,398,000 | |
| 139,984,000 | |
| 145,998,000 | |
| 150,292,000 | |
| 157,606,000 | |
| 164,823,000 | |
| 168,205,000 | |
| 172,256,000 | |
| 173,065,000 | |
| 165,801,000 | |
| 143,571,000 | |
| 120,647,000 | |
| 96,847,000 | |
| 77,951,000 | |
| 56,900,000 | |
| 36,944,000 |